Gümüşkaya Kılıç İrem, Ünver Hatice, Kargül Betül, Akbeyaz Şivet Ecem
Department of Pediatric Dentistry, School of Dentistry, Marmara University, Istanbul, Türkiye.
Department of Child and Adolescent Psychiatry, School of Medicine, Marmara University, Istanbul, Türkiye.
Clin Oral Investig. 2025 Sep 4;29(9):440. doi: 10.1007/s00784-025-06528-6.
This study aimed to evaluate and compare the effects of methylphenidate on oral health, salivary flow rate, and quality of life in children with Attention-Deficit/Hyperactivity Disorder (ADHD), focusing on differences between short-release methylphenidate (SRM) and long-release methylphenidate (LRM) formulations.
A total of 99 children participated in this cross-sectional study (ADHD: n = 49; divided into SRM (n = 27) and LRM (n = 22) subgroups based on medication type; control: n = 50). Dental caries was assessed using the DMFT/dft indices and the International Caries Detection and Assessment System (ICDAS), while oral hygiene was evaluated using the Plaque Index (PI), Gingival Index (GI), and Bleeding on Probing (BOP). Unstimulated salivary flow rates were measured. Salivary Streptococcus mutans and Lactobacillus levels were quantified using quantitative real-time polymerase chain reaction (qPCR). Quality of life was assessed with the Child Perceptions Questionnaire (CPQ) and KIDSCREEN-10. Logistic regression analyses examined associations between oral health outcomes, ADHD status, and medication type.
The ADHD group, especially SRM users, showed significantly higher DMFT scores, poorer oral hygiene, and reduced salivary flow rates compared to controls. Regression models further identified increased BOP and decreased salivary flow as predictors of ADHD and SRM use. qPCR confirmed higher Streptococcus mutans levels in SRM users. Quality of life was lower in ADHD children, particularly older SRM users.
Children with ADHD receiving methylphenidate exhibited poorer oral health and reduced quality of life, especially with SRM formulations.
Clinicians should be aware that children-particularly those receiving SRM-are more likely to present with reduced salivary flow, increased plaque accumulation, and gingival inflammation. Regular dental monitoring, reinforcement of oral hygiene practices, and dietary counseling should be integrated into the care plans of these patients.
本研究旨在评估和比较哌甲酯对注意力缺陷多动障碍(ADHD)儿童口腔健康、唾液流速和生活质量的影响,重点关注速释哌甲酯(SRM)和缓释哌甲酯(LRM)制剂之间的差异。
共有99名儿童参与了这项横断面研究(ADHD组:n = 49;根据用药类型分为SRM亚组(n = 27)和LRM亚组(n = 22);对照组:n = 50)。使用DMFT/dft指数和国际龋病检测与评估系统(ICDAS)评估龋齿情况,同时使用菌斑指数(PI)、牙龈指数(GI)和探诊出血(BOP)评估口腔卫生状况。测量非刺激性唾液流速。使用定量实时聚合酶链反应(qPCR)对唾液变形链球菌和乳酸杆菌水平进行定量分析。使用儿童感知问卷(CPQ)和儿童生活质量量表10项版(KIDSCREEN - 10)评估生活质量。逻辑回归分析检验口腔健康结果、ADHD状态和用药类型之间的关联。
与对照组相比,ADHD组,尤其是使用SRM的儿童,DMFT得分显著更高,口腔卫生状况更差,唾液流速更低。回归模型进一步确定,BOP增加和唾液流速降低是ADHD及使用SRM的预测因素。qPCR证实使用SRM的儿童变形链球菌水平更高。ADHD儿童的生活质量较低,尤其是年龄较大且使用SRM的儿童。
接受哌甲酯治疗的ADHD儿童口腔健康较差,生活质量降低,尤其是使用SRM制剂的儿童。
临床医生应意识到,儿童,尤其是接受SRM治疗的儿童,更有可能出现唾液流速降低、菌斑堆积增加和牙龈炎症。应将定期口腔检查、加强口腔卫生措施和饮食咨询纳入这些患者的护理计划。